Showing 5101-5110 of 10638 results for "".
Diagnosing and Managing Childhood Food Allergies
https://reachmd.com/programs/hot-topics-in-allergy/diagnosing-and-managing-childhood-food-allergies/3918/Because more children now live with food allergies than in decades past, at what point should a physician suspect that a patient might have a food allergy? What gastrointestinal symptoms are most common in children with food allergies? Dr. Scott Sicherer, associate professor of pediatrics at Mount SOCEAN Trial at AHA 2025: Anticoagulation After AF Ablation in High-Risk Patients
https://reachmd.com/clinical-practice/cardiology/ocean-trial-at-aha-2025-anticoagulation-after-af-ablation-in-high-risk-patients/48695/Review outcomes from the OCEAN trial assessing continued anticoagulation in patients with stroke risk factors after successful AF catheter ablation.Selecting Patients for Novel Breast Cancer Imaging Modalities: The Role of AI
https://reachmd.com/programs/project-oncology/selecting-patients-for-novel-breast-cancer-imaging-modalities-the-role-of-ai/26408/Here’s how AI risk assessments may be used to identify which patients should be screened for breast cancer using novel imaging modalities.Updates on New Technologies and Imaging Agents in Healthcare
https://reachmd.com/programs/project-oncology/updates-on-new-technologies-and-imaging-agents-in-healthcare/24058/What should we know about the use of AI in practice? Tune in.Empowering Patients with CIDP: Education, Support, and Personalized Care Strategies
https://reachmd.com/programs/frontlines-cidp/empowering-patients-with-cidp-education-support-and-personalized-care-strategies/33071/Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) presents unique challenges for newly diagnosed patients and their caregivers. Meeting patients where they are, identifying common misconceptions, and providing effective and individualized education can go a long way in creating an engEvaluating the Efficacy of Zuranolone for Postpartum Depression
https://reachmd.com/programs/advances-in-womens-health/evaluating-the-efficacy-of-zuranolone-for-postpartum-depression/32752/Zuranolone is the first oral drug approved by the FDA for the treatment of postpartum depression. Based on a recent systemic review and meta-analysis, it could provide rapid relief from symptoms within two weeks. Here to discuss the study’s findings and the potential impacts for patients suffering fOptimizing Medical Affairs Approaches with CME Best Practices
https://reachmd.com/programs/maps-chats/medical-affairs-cme-best-practices/56815/For medical affairs teams, demonstrating the value and impact of educational initiatives in a meaningful and measurable way is essential. At the 2026 Medical Affairs Professional Society (MAPS) Annual Meeting, Dr. Matt Birnholz spoke with Ms. Karen Roy, CEO and Co-Founder of Infograph-ed, about howDiagnosing Psoriatic Arthritis: A Real-World Case
https://reachmd.com/programs/living-rheum/diagnosing-psoriatic-arthritis-a-real-world-case/56347/Diagnosing psoriatic arthritis can be challenging, particularly when skin findings are subtle or hidden. In this case-based discussion, Dr. Lawrence H. Brent highlights key clinical clues and examination strategies from his own practice that can help clinicians identify psoriatic disease earlier andAdvances in Colorectal Cancer Detection: Exploring the Role of Blood-Based Tests
https://reachmd.com/programs/gi-insights/advances-in-colorectal-cancer-detection-exploring-the-role-of-blood-based-tests/39215/Blood-based colorectal cancer screening is entering a new era with FDA-approved and emerging tests like Shield and Simple Screen. Alongside updated stool-based options such as Cologuard Plus and CRC-PREVENT, clinicians now have a broader landscape of noninvasive tools to consider and discuss with thAdvancing Noninvasive CRC Screening: Exploring an Aptamer-Based Assay
https://reachmd.com/programs/project-oncology/advancing-noninvasive-crc-screening-exploring-an-aptamer-based-assay/36407/With one in three eligible Americans still unscreened for colorectal cancer (CRC), there’s an urgent need for noninvasive and affordable alternatives to colonoscopy. A 2025 study published in ACS Sensors introduces a novel aptamer-based colorimetric assay that targets Parvimonas micra—a gut microbe